• Produto
    • Produto
    • Fornecedor
Avançado

TTY Biopharm Expands Anti-cancer Drug Production

Source: Taiwantrade | Updated: 25 January 2013

TTY Biopharm announced a new factory in China in November last year in a bid to expand in the regional market. The US$100m facility is planned for the production of anti-cancer drug injections.

 

The company also recently implemented a new facility in Chungli, Taiwan to produce anti-cancer injection. The Chungli facility is planned to begin large volume shipments.

 

The company has been reported to estimate the facility’s yearly production volume to reach 800,000 to one million shots in 2013.

 

Recomendações

Loading ...

Recomendação para Pequenas Quantidades

Loading ...